Recent Quotes (30 days)

You have no recent quotes
chg | %

Avivagen Inc  

(Public, CVE:VIV)   Watch this stock  
Find more results for CVE:CFR
+0.005 (5.26%)
Mar 23 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.10 - 0.10
52 week 0.04 - 0.22
Open 0.10
Vol / Avg. 349,640.00/529,440.00
Mkt cap 29.07M
P/E     -
Div/yield     -
EPS -0.01
Shares 290.65M
Beta 0.89
Inst. own     -

Key stats and ratios

Q1 (Jan '17) 2016
Net profit margin -1636.48% -1707.61%
Operating margin -1636.48% -1707.61%
EBITD margin - -1611.21%
Return on average assets -76.18% -93.48%
Return on average equity -742.68% -
CDP Score - -


100 Sussex Drive
+1-613-9498164 (Phone)
+1-613-9498164 (Fax)

Website links


Avivagen Inc. is a life sciences company. The Company is developing and commercializing products to replace antibiotics in livestock feeds for growth promotion and to help prevent disease by supporting the animal's own health defenses. It operates through two segments: products based on fully-oxidized beta-carotene (OxC-beta) technology and chemistry product sales. Its OxC-beta technology is in trials as a non-antibiotic feed additive. Its products include OxC-beta Livestock, Vivamune Vital Health3 Chews and Oximunol Chewable Tablets. Its Vivamune Vital Health3 Chews are natural supplements that are suitable for pets in all life stages and can be given to dogs and cats as young as six weeks of age. The Oximunol Chewable Tablets are available in bottles of 50, through veterinarians across the United States. It develops science-based, natural health products for animals that are proven in clinical trials. The OxC-beta Livestock is available for sale in Thailand and the Philippines.

Officers and directors

G.F. Kym Anthony Chairman of the Board, Interim Chief Executive Officer
Chris Boland Chief Financial Officer
David Hankinson Executive Director
Drew Basek Director of Investor Relations
Graham Burton Director - Commercialization Science, Director
Louis Hui Director - Business Development
Paul Mesburis Lead Director
David G. P. Allan Director
Vanessa Grant Director
Amin I. Khalifa Independent Director